<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number: 0-19352
NOTIFICATION OF LATE FILING OF FORM 10-KSB
For the Period Ended June 30, 1997
PART 1. REGISTRANT INFORMATION
Full name of registrant: AgriBioTech, Inc.
-----------------
Former name if applicable: N/A
Address of Principal executive office (Street and number):
2700 Sunset Road, Suite C-25
- ----------------------------
(City, State and Zip Code): Las Vegas, Nevada 89120
------------------------
PART II. RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense, and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[ X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[ X] (b) The subject annual report on Form 10-KSB will be filed on or before
the fifteenth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why Form 10-KSB could not be
filed within the prescribed time period:
Certain developments over the past few days have required the Registrant to
devote substantially all of its attention and energy to certain business
matters. Accordingly, the Registrant is unable to complete and file its Form 10-
KSB within the prescribed time period without unreasonable effort and expense.
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
<PAGE>
Henry A. Ingalls (702) 798-1969
(Name) (Area Code) (Telephone number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding 12 months or for such
shorter period that the registrant was required to file such reports(s) been
filed? If the answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
AgriBioTech, Inc.
-------------------------------------------
(Name of registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: September 29, 1997 By: /s/ Henry A. Ingalls
------------------------------
Henry A. Ingalls
Title: Chief Financial Officer
Instruction. The form may be signed by an executive officer of the
-----------
registrant or by any other duly authorized representative. If the statement is
signed on behalf of the registrant by an authorized representative (other than
an executive officer), evidence of the representative's authority to sign on
behalf of the registrant shall be filed with the form.
ATTENTION:
Intentional missstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).
---
